On Tuesday, Harmony Biosciences Holdings Inc (NASDAQ: HRMY) was 6.18% up from the session before settling in for the closing price of $30.92. A 52-week range for HRMY has been $18.61 – $39.26.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 546.41% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 3.42%. With a float of $30.65 million, this company’s outstanding shares have now reached $56.77 million.
In an organization with 246 employees, it is important to assess its efficiency.
Harmony Biosciences Holdings Inc (HRMY) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Harmony Biosciences Holdings Inc stocks. The insider ownership of Harmony Biosciences Holdings Inc is 46.03%, while institutional ownership is 63.56%. The most recent insider transaction that took place on Mar 15 ’24, was worth 383,328. In this transaction CHIEF COMMERCIAL OFFICER of this company sold 11,979 shares at a rate of $32.00, taking the stock ownership to the 0 shares. Before that another transaction happened on Mar 08 ’24, when Company’s CHIEF COMMERCIAL OFFICER sold 194 for $32.00, making the entire transaction worth $6,208. This insider now owns 0 shares in total.
Harmony Biosciences Holdings Inc (HRMY) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.65 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 3.42% per share during the next fiscal year.
Harmony Biosciences Holdings Inc (NASDAQ: HRMY) Trading Performance Indicators
You can see what Harmony Biosciences Holdings Inc (HRMY) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.07. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.02. Likewise, its price to free cash flow for the trailing twelve months is 8.98.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.32, a number that is poised to hit 0.68 in the next quarter and is forecasted to reach 3.71 in one year’s time.
Technical Analysis of Harmony Biosciences Holdings Inc (HRMY)
Let’s dig in a bit further. During the last 5-days, its volume was 0.49 million. That was better than the volume of 0.39 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 37.34%. Additionally, its Average True Range was 1.59.
During the past 100 days, Harmony Biosciences Holdings Inc’s (HRMY) raw stochastic average was set at 67.97%, which indicates a significant increase from 58.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 43.30% in the past 14 days, which was higher than the 39.55% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $31.40, while its 200-day Moving Average is $30.43. However, in the short run, Harmony Biosciences Holdings Inc’s stock first resistance to watch stands at $34.75. Second resistance stands at $36.66. The third major resistance level sits at $38.43. If the price goes on to break the first support level at $31.07, it is likely to go to the next support level at $29.30. The third support level lies at $27.39 if the price breaches the second support level.
Harmony Biosciences Holdings Inc (NASDAQ: HRMY) Key Stats
There are 56,792K outstanding shares of the company, which has a market capitalization of 1.86 billion. As of now, sales total 582,020 K while income totals 128,850 K. Its latest quarter income was 154,620 K while its last quarter net income were 38,330 K.
